Catalyst
Slingshot members are tracking this event:
Phase 2 LIBERTY Study of Ubenimex in Pulmonary Arterial Hypertension expected to read out in Q1 2018
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| EIGR |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 16, 2018
Occurred Source:
http://www.eigerbio.com/news/
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Ubenimex, Pah, Pulmonary Arterial Hypertension
